Company Quick10K Filing
GeoVax Labs
10-Q 2020-09-30 Filed 2020-11-05
S-1 2020-07-20 Public Filing
10-Q 2020-06-30 Filed 2020-08-10
10-Q 2020-03-31 Filed 2020-05-05
10-K 2019-12-31 Filed 2020-03-24
10-Q 2019-09-30 Filed 2019-11-07
10-Q 2019-06-30 Filed 2019-08-13
10-Q 2019-03-31 Filed 2019-05-13
10-K 2018-12-31 Filed 2019-03-26
10-Q 2018-09-30 Filed 2018-11-08
10-Q 2018-06-30 Filed 2018-08-07
10-Q 2018-03-31 Filed 2018-05-03
10-K 2017-12-31 Filed 2018-03-23
10-Q 2017-09-30 Filed 2017-11-09
10-Q 2017-06-30 Filed 2017-08-14
10-Q 2017-03-31 Filed 2017-05-12
10-K 2016-12-31 Filed 2017-03-24
10-Q 2016-09-30 Filed 2016-11-14
10-Q 2016-06-30 Filed 2016-08-05
10-Q 2016-03-31 Filed 2016-05-04
10-K 2015-12-31 Filed 2016-03-16
10-Q 2015-09-30 Filed 2015-11-12
10-Q 2015-06-30 Filed 2015-08-04
10-Q 2015-03-31 Filed 2015-05-14
10-K 2014-12-31 Filed 2015-03-20
10-Q 2014-09-30 Filed 2014-11-12
10-Q 2014-06-30 Filed 2014-08-08
10-Q 2014-03-31 Filed 2014-05-02
10-K 2013-12-31 Filed 2014-03-14
10-Q 2013-09-30 Filed 2013-11-12
10-Q 2013-06-30 Filed 2013-08-12
10-Q 2013-03-31 Filed 2013-05-01
10-K 2012-12-31 Filed 2013-03-18
10-Q 2012-09-30 Filed 2012-11-13
10-Q 2012-06-30 Filed 2012-08-13
10-Q 2012-03-31 Filed 2012-05-14
10-Q 2011-09-30 Filed 2011-11-10
10-Q 2011-06-30 Filed 2011-08-12
10-Q 2011-03-31 Filed 2011-04-27
10-K 2010-12-31 Filed 2011-03-04
10-Q 2010-09-30 Filed 2010-11-08
10-Q 2010-06-30 Filed 2010-08-06
10-Q 2010-03-31 Filed 2010-05-04
10-K 2009-12-31 Filed 2010-03-08
8-K 2021-02-11 Enter Agreement, Other Events, Exhibits
8-K 2021-02-08 Enter Agreement, Other Events
8-K 2020-11-25
8-K 2020-11-05
8-K 2020-10-22
8-K 2020-09-29
8-K 2020-09-24
8-K 2020-08-25
8-K 2020-08-10
8-K 2020-08-07
8-K 2020-06-26
8-K 2020-06-19
8-K 2020-05-18
8-K 2020-05-06
8-K 2020-04-17
8-K 2020-03-25
8-K 2020-03-06
8-K 2020-01-23
8-K 2020-01-21
8-K 2020-01-03
8-K 2019-11-14
8-K 2019-11-07
8-K 2019-10-24
8-K 2019-10-16
8-K 2019-10-01
8-K 2019-09-30
8-K 2019-08-14
8-K 2019-08-02
8-K 2019-07-24
8-K 2019-07-16
8-K 2019-06-19
8-K 2019-05-14
8-K 2019-04-30
8-K 2019-04-26
8-K 2019-04-15
8-K 2019-03-27
8-K 2019-02-25
8-K 2019-02-18
8-K 2019-01-22
8-K 2018-12-27
8-K 2018-11-08
8-K 2018-08-31
8-K 2018-08-13
8-K 2018-08-07
8-K 2018-06-14
8-K 2018-05-03
8-K 2018-03-23
8-K 2018-03-05

GeoVax Labs Financials

GOVX Metrics, Comps, Filings

Quarterly | Annual

Valuation ($MM)

Market Cap, Enterprise Value

Balance Sheet ($MM)

Assets, Equity

Income Statement ($MM Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($MM Quarterly)

Ops, Inv, Fin

Comps ($'000 TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
024 Pharma (EEIG)
11 Good Energy (ELVN)
1347 Capital Corp (TFSC)
Ameren Illinois Co (AILNP)
1PM Industries (OPMZ)
1st Century Bancshares (FCTY)
1st Financial Services Corp (FFIS)
1st United Bancorp (FUBC)
2-Track Global (TTG)
ENTERGY ARKANSAS, LLC (EAI)
21st Century Oncology Holdings (RTSX)
24Holdings (TWFH)
Bioquest Corp (BQST)
30DC (TDCH)
BriaCell Therapeutics Corp. (BCTXW)
DD3 Acquisition Corp. II (DDMXW)
3D Total Solutions (DTLS)
3DX Industries (DDDX)
8i Acquisition 2 Corp. (LAX)
ALABAMA POWER CO (APRCP)

Balance Sheet ($'000)2011-06-302011-09-302011-12-312011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash6685671,1681,1682,2401,8171,5841,0361,7511,8811,7212,5142,0101,3728621,1023,1472,4761,8211,060669215511454167823344313571191511260176216569
Accounts Receivable
Inventory
PP&E2071861761761581391215328772144619619630654654670670670670670670670670675675675675675675675675679679679
Assets2,1341,8131,6451,6452,8372,2902,0361,4782,1302,0441,9612,8402,1731,5211,0531,3333,3592,6641,9981,332796339675610304990496490840371623642473343817
Accounts Payable138138184296916411139851561351158256461114210110339337615115211878546614812625311663
Long-Term Debt49464340353229
Liabilities7316509429425103803383273501522263122352371701872171811181271661802533705486527328119681,1141,3481,6641,6801,6711,837
Stockholders' Equity1,4041,1627047042,3271,9101,6981,1511,7801,8931,7362,5271,9381,2838831,1463,1422,4831,8801,205630159423240-244338-236-321-129-743-724-1,022-1,207-1,329-1,021
Income Statement ($'000)2011-06-302011-09-302011-12-312011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Revenue22193349364210333
Cost of Revenue
Gross Profit
R&D1,3851,0909639631,072712602657882553879601403516425468385379526438398684451552518498449487372558556451468
SG&A5795831,1481,148513492334413613416316447372345412679365336327907345221659293352340247357359459510413291
Tax00000000000
Net Income-211-376-1,153-1,153-731-498-297-610-697-526-190-872-616-680-515-924-700-676-620-693-1,296-576-464-935-548-517-589-516-622-637-667-701-654-424
Cash Flow ($'000)2011-06-302011-09-302011-12-312011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash Operating-527575-1,237-423-233-548-344-453-74-823-504-627-485-634-619-671-655-761-629-545-332-429-448-382-380-280-317-456-344
Cash Investing0-12-12000000-870-240-1600000-400000-400
Cash Financing-495395392,3090001,0605831,61602,68000023891491,0854176400600238497697